CliffBio
biologic

Gonal-f

follitropin alfa

Loss of exclusivityMarch 2016projected — 12-year biologic exclusivity estimate
CompanyEMD Serono →See this company's full patent-cliff portfolio

Drug detail

Brand nameGonal-f
Active ingredientfollitropin alfa
Strength450IU (600IU/ML)
Dosage formFor Injection
RouteSubcutaneous
ModalityBiologic
FDA approvalMarch 2004
Marketing statusRx

More from EMD Serono

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.

Gonal-f patent cliff — loss of exclusivity March 2016 | CliffBio